Prefilled Syringes Market Size, Global Driving Factors 2022

NEW YORK - Nov. 9, 2022 - PRLog -- The global prefilled syringes market size was valued at USD 18.52 billion in 2021 and is projected to reach USD 40.58 billion by 2028 at CAGR of 11.86% during forecast period 2022-28.  A pre-filled syringe is a single-dose, disposable syringe that contains a preloaded material, generally a medication or vaccination, that is injected using a needle. Pre-filled syringes with pre-measured doses aid in the reduction of dosing mistakes and improve patient compliance. With the exception of vials, which are often 20-30% overfilled, resulting in possible waste, pre-filled syringes completely eliminate the requirement for overfilling by the manufacturer. Pre-filled syringes are considered to be a more economical, accessible, and reliable method of medication delivery for healthcare personnel. They're currently employed in a variety of therapeutic fields. Furthermore, the prefilled syringes ease of use has made it more adaptive among patients. Metal and glass syringes were often used in the past, but disposable plastic syringes with single-use needles have become more popular in recent years. A few benefit of having a pre-filled syringe are that it saves time during emergency outbreaks, it is inexpensive, it works to prevent transmission owing to its one-time use benefit, it allows you to self-inject medication, it has little or no breaking, and it is easy to use.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-pre-filled-syringes-market/

The Prefilled Syringes Market is fragmented based on Type, Material, Design and Geography. In terms of Material, the market is fragmented into Glass Pre filled Syringes and Plastic Pre filled Syringes. In terms of Type, the market is categorized into Safety Prefilled Syringes and Conventional Prefilled Syringes. Based on Design, the market is bifurcated into Single chamber prefilled syringes, Dual Chamber prefilled syringes & Customized prefilled syringes.

Europe has been the biggest market for prefilled syringes as well as a key income source. The increase in chronic and lifestyle illnesses, technical developments, better resistance and accessibility of prefilled syringes, and geographic coverage are the key reasons that have contributed to the rise of prefilled syringes in Europe markets.

There are several industry players working in the prefilled syringes market, which include Becton, Dickinson and Company (U.S.), Catalent, Inc. (U.S.), Gerresheimer (Germany), Haselmeier (Switzerland), MedPro Inc. (U.S.), Nipro Corporation (Japan), Ompi (Italy), Owen Mumford (UK), SCHOTT AG (Germany), Terumo Medical Corporation (Japan), Unilife Corporation (U.S.), Vetter Pharma International GmbH (Germany), Weigao Group (China), West Pharmaceutical Services, Inc. (U.S.), Ypsomed Holding AG (Switzerland)